HT
AVDL

HAP Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

HAP Trading’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.05M Buy
68,962
+26,130
+61% +$340K 0.07% 172
2025
Q2 		$379K Buy
42,832
+6,986
+19% +$61.4K 0.04% 227
2025
Q1 		$281K Buy
+35,846
New +$300K 0.03% 262

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

HAP Trading's AVDL Position: Q3 2025 in Review

HAP Trading increased its Avadel Pharmaceuticals (AVDL) stake by 61% in Q3 2025, buying an estimated $340K and bringing the position to 68,962 shares worth $1.05M. The position accounts for 0.07% of the portfolio, ranked #172.

HAP Trading first reported a position in AVDL in Q1 2025 and has held it in 3 quarters since. 188 funds tracked by Wall St. Rank hold AVDL as of Q3 2025.

  • HAP Trading held 68,962 shares of Avadel Pharmaceuticals worth $1.05M as of Q3 2025.
  • HAP Trading bought 26,130 Avadel Pharmaceuticals shares in Q3 2025, an estimated $340K.
  • Avadel Pharmaceuticals made up 0.07% of HAP Trading's portfolio in Q3 2025, its #172 holding.
  • HAP Trading first reported a position in Avadel Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 188 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.